Search

Displaying results 8801 - 8810 of 10000 in total
  1. Drug

    Retezorogant

    go.drugbank.com/drugs/DB21592
    Experimental

    The usage of the INN stem '-rogant' in the name indicates that Retezorogant is a retinoic acid receptor-related orphan receptor gamma (RORY) antagonist and inverse agonist.

  2. Drug

    Progranulin

    go.drugbank.com/drugs/DB18430
    Experimental

    Categories: Amino Acids, Peptides, and Proteins, Intercellular Signaling Peptides and Proteins
  3. Drug

    Piprozolin

    go.drugbank.com/drugs/DB13202
    Experimental

    Categories: Bile and Liver Therapy, Alimentary Tract and Metabolism
  4. Drug

    Epomediol

    go.drugbank.com/drugs/DB13802
    Experimental

    Categories: Bile and Liver Therapy, Cholagogues and Choleretics
  5. Drug

    Dipyrocetyl

    go.drugbank.com/drugs/DB13839
    Experimental

    Categories: Salicylic Acid and Derivatives, dipyrocetyl and corticosteroids
  6. Drug

    Pralnacasan

    go.drugbank.com/drugs/DB04875
    Experimental

    Pralnacasan is an orally bioavailable pro-drug of a potent, non-peptide inhibitor of interleukin-1beta converting enzyme (ICE).

  7. Drug

    Cyanamide

    go.drugbank.com/drugs/DB02679
    Experimental

    A cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. It often occurs as the calcium salt, sometimes also referred to as cyanamide.

  8. Drug

    Iolopride I-123

    go.drugbank.com/drugs/DB20028
    Experimental

    The usage of the INN stem '-pride' in the name indicates that Iolopride I-123 is a sulpiride derivative and analogue. Iolopride I-123 has a monoisotopic molecular weight of 400.06 Da.

  9. Drug

    Cinaciguat

    go.drugbank.com/drugs/DB16126
    Investigational

    Cinaciguat is under investigation in clinical trial NCT01067859 (A Phase Iib Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 ΜG/h, 10 ΜG/h) Given Intravenously to Patients

  10. Drug

    Ninerafaxstat

    go.drugbank.com/drugs/DB21486
    Investigational

    Ninerafaxstat is under investigation in clinical trial NCT07023614 (A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy